講演情報

[O8-01]Efficacy and immunogenicity evaluation of mRNA-lipid nanoparticle vaccines for Lassa virus in surrogate mouse models of infection

Mei Hashizume1, Ayako Takashima1, *Masaharu Iwasaki1,2,3,4 (1. Research Institute for Microbial Diseases, Osaka University (Japan), 2. Center for Infectious Disease Education and Research, Osaka University (Japan), 3. Center for Advanced Modalities and Drug Delivery System, Osaka University (Japan), 4. RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan))